Is the process of withdrawal of life-sustaining measures in the intensive care unit different for deceased organ donors compared with other dying patients? A secondary analysis of prospectively collected data.

Adult anaesthesia Adult intensive & critical care Adult palliative care MEDICAL ETHICS TRANSPLANT MEDICINE Transplant medicine

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
18 08 2023
Historique:
medline: 21 8 2023
pubmed: 20 8 2023
entrez: 19 8 2023
Statut: epublish

Résumé

To investigate whether observable differences exist between patterns of withdrawal of life-sustaining measures (WLSM) for patients eligible for donation after circulatory death (DCD) in whom donation was attempted compared with those patients in whom no donation attempts were made. Adult intensive care units from 20 centres in Canada, the Czech Republic and the Netherlands. Secondary analysis of quantitative data collected as part of a large, prospective, cohort study (the Death Prediction and Physiology after Removal of Therapy study). Patients ≥18 years of age who died after a controlled WLSM in an intensive care unit. Patients were classified as not DCD eligible, DCD eligible with DCD attempted or DCD eligible but DCD was not attempted. The process of WLSM (timing and type and, if applicable, dosages of measures withdrawn, dosages of analgesics/sedatives) was compared between groups. Of the 635 patients analysed, 85% had either cardiovascular support stopped or were extubated immediately on WLSM. Of the DCD eligible patients, more were immediately extubated at the initiation of WLSM when DCD was attempted compared with when DCD was not attempted (95% vs 61%, p<0.0001). Initiation of WLSM with the immediate cessation of cardiovascular measures or early extubation was associated with earlier time to death, even after adjusting for confounders (OR 2.94, 95% CI 1.39 to 6.23, at 30 min). Other than in a few patients who received propofol, analgesic and sedative dosing after WLSM between DCD attempted and DCD eligible but not attempted patients was not significantly different. All patients died. Patients in whom DCD is attempted may receive a different process of WLSM. This highlights the need for a standardised and transparent process for end-of-life care across the spectrum of critically ill patients and potential organ donors.

Identifiants

pubmed: 37597867
pii: bmjopen-2022-069536
doi: 10.1136/bmjopen-2022-069536
pmc: PMC10441082
doi:

Substances chimiques

Hypnotics and Sedatives 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e069536

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: LH is a paid consultant for Canadian Blood Services. SD is a paid Hospital Donation Physician for Ontario Health.

Références

Can J Anaesth. 2020 Nov;67(11):1549-1556
pubmed: 32918249
Transplant Proc. 2020 Dec;52(10):2867-2876
pubmed: 33004222
PLoS Med. 2007 Oct 16;4(10):e296
pubmed: 17941714
Crit Care Med. 1985 Oct;13(10):818-29
pubmed: 3928249
J Med Ethics. 2017 Jan;43(1):47-51
pubmed: 27738255
J Intensive Care Med. 2017 Mar;32(3):179-186
pubmed: 26905540
Transplant Direct. 2018 Jun 27;4(7):e368
pubmed: 30046658
Intensive Care Med. 2016 Jun;42(6):1003-17
pubmed: 27059793
N Engl J Med. 2021 Jan 28;384(4):345-352
pubmed: 33503343
Crit Care Med. 2015 Oct;43(10):e450-7
pubmed: 26121072
Am J Transplant. 2018 Apr;18(4):890-896
pubmed: 28980398
Palliat Med. 2020 Oct;34(9):1140-1164
pubmed: 32597309
Can Fam Physician. 2011 Nov;57(11):1257-66, e407-18
pubmed: 22084455

Auteurs

J Shahin (J)

Division of Critical Care, Respiratory Epidemiology and Clinical Research Unit, McGill University Faculty of Medicine, Montreal, Québec, Canada Jason.shahin@mcgill.ca.
Research Institute of the McGill University Health Centre, Montreal, Québec, Canada.

Nathan B Scales (NB)

Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

F Johara (F)

Research Institute of the McGill University Health Centre, Montreal, Québec, Canada.

M Hogue (M)

CHEO, Ottawa, Ontario, Canada.

Laura Hornby (L)

System Development, Canadian Blood Services Organ Donation and Transplantation, Ottawa, Ontario, Canada.

Sam Shemie (S)

Division of Critical Care, Department of Pediatrics, Montreal Childrens Hospital, Montreal, Québec, Canada.
System Development, Canadian Blood Services, Ottawa, Ontario, Canada.

M Schmidt (M)

Third Faculty of Medicine, Charles University, Praha, Czech Republic.
FNKV University Hospital, Prague, Czech Republic.

P Waldauf (P)

Third Faculty of Medicine, Charles University, Praha, Czech Republic.
FNKV University Hospital, Prague, Czech Republic.

F Duska (F)

Third Faculty of Medicine, Charles University, Praha, Czech Republic.
FNKV University Hospital, Prague, Czech Republic.

Tineke Wind (T)

Maastricht University Medical Centre, Maastricht, The Netherlands.
Heart and Vascular Center, Maastricht, The Netherlands.

W N Van Mook (WN)

Deparment of Intensive Care Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.

Sonny Dhanani (S)

Critical Pediatric Critical Care Medicine, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH